NEW YORK, Feb 8, 2026, 06:40 EST — The session has wrapped up.
Shares of Palantir Technologies Inc (PLTR) climbed 4.5% to finish Friday at $135.90, with beaten-down software stocks drawing some late-week interest. U.S. markets remain closed on Sunday, so investors are left wondering if the rally has legs when trading resumes Monday.
AI stocks found their footing following a rough patch for software names, with chipmakers climbing as bets on boosted AI infrastructure spending picked up. Shares of Palantir and CrowdStrike each jumped over 4% Friday, according to Reuters. Baird’s Ross Mayfield pointed to “real demand for AI products” running underneath the volatility. Reuters
This week’s wild swings in Palantir saw shares climb 6.9% on Feb. 3, only to skid 11.6% the following session, then dip another 6.8% on Feb. 5, before bouncing back Friday, according to Investing.com data.
Wild price moves came on the heels of the company’s latest results and a bullish forecast. Palantir logged a 70% jump in fourth-quarter revenue to $1.41 billion, and projected 2026 revenue between $7.18 billion and $7.20 billion. CEO Alex Karp said in a note that protecting privacy hinges on “granular permissioning capabilities.” But eToro’s Zavier Wong called the shares “priced for perfection.” Reuters
Palantir has been active on deal chatter again. On Thursday, Cognizant announced it would blend Palantir Foundry and its Artificial Intelligence Platform with its own TriZetto healthcare tools. Surya Gummadi from Cognizant pitched the move as an effort to bring “frontier technologies” to customers. Palantir’s Eric Lakin added his take: “Enterprise AI doesn’t fail because models are weak.” News | Cognizant Technology Solutions
Traders have also been watching insider moves. According to a Form 4, director Alexander D. Moore unloaded 20,000 Class A shares on Feb. 2 through a Rule 10b5-1 plan — that’s a pre-arranged trade — with sale prices between roughly $146.75 and $151.14. He’s still holding 1,172,978 shares.
Still, Palantir’s government connections come with complications. In the UK, pressure has mounted to suspend or stop public contracts with the company over concerns about the opacity of NHS and defense agreements, according to the Guardian.
Forget Denver for now — next week, it’s Washington that’s likely to move markets. The government drops January jobs numbers on Wednesday, Feb. 11, with the print hitting at 8:30 a.m. ET. Two days later, on Friday, Feb. 13, the CPI report lands at the same time. Both releases routinely shake up rate expectations and sway demand for pricey growth shares.
Related articles: NASDAQ:CRWD
